David Dodick
Neurology · New York, NYNPI 1417931577
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $351,804 of the $425,839 with a category attached, or 82.6%. 13 manufacturers reported payments, led by Amgen at 34.5% of the total. Reporting peaked in 2020 at $149,904 and has fallen 98.9% since, to $1,600 in 2025. Among neurology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 279 payments — averaging $1526.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$147K
- AbbVie$115K
- Lilly USA, LLC$40K
- Genentech, Inc.$31K
- H. Lundbeck A S$29K
- Eli Lilly$15K
- plus $49K from 7 others
Across 24 payments — averaging $1990.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$44K
- Pfizer$3K
- F. Hoffmann-la Roche AG$1K
What the payments were for
- Consulting fees$351,80483%
- Speaking & faculty fees$54,05713%
- Travel & lodging$17,1204%
- Food & beverage$2,7531%
- Education$1050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 144 | $147,120 |
| AbbVie(2 entities) | 73 | $114,799 |
| Lilly USA, LLC | 9 | $40,063 |
| Genentech, Inc. | 11 | $31,174 |
| H. Lundbeck A S | 7 | $28,750 |
| Eli Lilly | 12 | $15,394 |
| Lundbeck LLC | 5 | $12,907 |
| Novartis Pharma AG | 7 | $12,032 |
| W. L. Gore & Associates, Inc. | 3 | $7,350 |
| Pfizer | 3 | $7,011 |
| Biohaven Pharmaceuticals, Inc. | 3 | $4,300 |
| Ipsen Innovation | 1 | $4,290 |
| Biodelivery Sciences International, Inc. | 1 | $650 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIMOVIG$134,188
- BOTOX$32,968
- UBRELVY$31,718
- EMGALITY$28,638
- VYEPTI$12,250
- NURTEC ODT$10,500
- AMG334A_AIMOVIG_NEUROSCIENCE$8,135
- BOTOX COSMETIC$4,800
- Product in Development$4,500
- AMG334_AIMOVIG_NEUROSCIENCE$3,897
- CARDIOFORM Septal Occluder$2,850
- Prolia$2,500
How this compares
$425,839 in reported general payments places this provider in the 95th percentile of 1,623 neurology providers in New York.
Other neurology in New York
- Stephen KriegerNew York$1.1M
- Sheng-Han KuoNew York$657K
- Timothy VartanianNew York$468K
- Steven WolfNew York$428K
- David SimpsonNew York$403K
- Fred LublinNew York$383K
- Alexander ShtilbansNew York$374K
- Andrew LassmanNew York$359K
- Brian ApatoffNew York$295K
- Aaron MillerNew York$280K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.